Free Trial
NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

China SXT Pharmaceuticals logo
$1.34 -0.08 (-5.63%)
As of 10:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

Advanced

Key Stats

Today's Range
$1.29
$1.40
50-Day Range
$1.38
$1.98
52-Week Range
$0.95
$7.84
Volume
14,771 shs
Average Volume
1.51 million shs
Market Capitalization
$155.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

China SXT Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

SXTC MarketRank™: 

China SXT Pharmaceuticals scored higher than 24% of companies evaluated by MarketBeat, and ranked 836th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Book Value per Share Ratio

    China SXT Pharmaceuticals has a P/B Ratio of 0.07. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.13% of the outstanding shares of China SXT Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    China SXT Pharmaceuticals has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in China SXT Pharmaceuticals has recently decreased by 54.05%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    China SXT Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    China SXT Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.13% of the outstanding shares of China SXT Pharmaceuticals have been sold short.
  • Short Interest Ratio / Days to Cover

    China SXT Pharmaceuticals has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in China SXT Pharmaceuticals has recently decreased by 54.05%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    China SXT Pharmaceuticals has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for China SXT Pharmaceuticals this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, China SXT Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.95% of the stock of China SXT Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 5.02% of the stock of China SXT Pharmaceuticals is held by institutions.

  • Read more about China SXT Pharmaceuticals' insider trading history.
Receive SXTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SXTC Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
China SXT Pharmaceuticals, Inc. (SXTC) - Yahoo Finance
China SXT Pharmaceuticals Inc Ordinary Shares
See More Headlines

SXTC Stock Analysis - Frequently Asked Questions

China SXT Pharmaceuticals' stock was trading at $4.0648 on January 1st, 2025. Since then, SXTC stock has decreased by 65.1% and is now trading at $1.42.

China SXT Pharmaceuticals's stock reverse split before market open on Tuesday, February 25th 2025.The 1-8 reverse split was announced on Friday, February 21st 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that China SXT Pharmaceuticals investors own include Marathon Digital (MARA), NIO (NIO), Meta Platforms (META), Alibaba Group (BABA), HEXO (HEXO), JD.com (JD) and Blink Charging (BLNK).

Company Calendar

Today
10/22/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SXTC
CIK
1723980
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
3.54
Quick Ratio
3.40

Sales & Book Value

Annual Sales
$1.74 million
Price / Sales
94.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$21.35 per share
Price / Book
0.07

Miscellaneous

Outstanding Shares
116,030,000
Free Float
111,445,000
Market Cap
$164.76 million
Optionable
Not Optionable
Beta
1.36
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:SXTC) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners